Biomarkers in sarcopenia: A multifactorial approach

Experimental Gerontology

Volumn 85, Issue , 2016, Pages 1-8

  Curcio, Francesco ^a   Ferro, Gaetana ^a   Basile, Claudia ^a   Liguori, Ilaria ^a   Parrella, Paolo ^a   Pirozzi, Flora ^a   Della Morte, David ^b,c   Gargiulo, Gaetano ^d   Testa, Gianluca ^e   Tocchetti, Carlo Gabriele ^a   Bonaduce, Domenico ^a   Abete, Pasquale ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

^e UNIVERSITY OF MOLISE   (Italy)

Author keywords

Biomarkers; Diagnosis; Elderly; Sarcopenia

Indexed keywords

3 METHYLHISTIDINE; ACTIVIN A; ALBUMIN; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; C TERMINAL AGRIN FRAGMENT; COMPLEMENT COMPONENT C1Q; CREATININE; FOLLISTATIN; GROWTH DIFFERENTIATION FACTOR 15; GROWTH HORMONE; HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; IRISIN; LEPTIN; MYELOPID; MYOSTATIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PRASTERONE; PROCOLLAGEN; SOMATOMEDIN C; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA; TROPONIN T; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIC ACID; VITAMIN D;

ENDOCRINE SYSTEM; FRAIL ELDERLY; GRIP STRENGTH; HUMAN; MUSCLE MASS; NEUROMUSCULAR JUNCTION; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; SARCOPENIA; SARCOPENIC OBESITY; AGED; AGING; DAILY LIFE ACTIVITY; HAND STRENGTH; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ACTIVITIES OF DAILY LIVING; AGED; AGING; BIOMARKERS; HAND STRENGTH; HUMANS; MUSCLE, SKELETAL; SARCOPENIA;

EID: 84988472780     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2016.09.007     Document Type: Review

References (111)

1. Abreu, E.L., Cheng, A.L., Kelly, P.J., Chertoff, K., Brotto, L., Griffith, E., Kinder, G., Uridge, T., Zachow, R., Brotto, M., Skeletal muscle troponin as a novel biomarker to enhance assessment of the impact of strength training on fall prevention in the older adults. Nurs. Res. 63 (2014), 75–82.
2. Argilés, J.M., López-Soriano, J., Almendro, V., Busquets, S., López-Soriano, F.J., Cross-talk between skeletal muscle and adipose tissue: a link with obesity?. Med. Res. Rev. 25 (2005), 49–65.
3. Barbat-Artigas, S., Dupontgand, S., Pion, C.H., Feiter-Murphy, Y., Aubertin-Leheudre, M., Identifying recreational physical activities associated with muscle quality in men and women aged 50 years and over. J. Cachex. Sarcopenia Muscle 5 (2014), 221–228.
4. Baumgartner, R.N., Koehler, K.M., Gallagher, D., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147 (1998), 755–763.
5. Beyer, I., Mets, T., Bautmans, I., Chronic low-grade inflammation and age-related sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 15 (2012), 12–22.
6. Bhasin, S., Calof, O.M., Storer, T.W., Lee, M.L., Mazer, N.A., Jasuja, R., Montori, V.M., Gao, W., Dalton, J.T., Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat. Clin. Pract. Endocrinol. Metab. 2 (2006), 146–159.
7. Bhasin, S., He, E.J., Kawakubo, M., Schroeder, E.T., Yarasheski, K., Opiteck, G.J., Reicin, A., Chen, F., Lam, R., Tsou, J.A., Castaneda-Sceppa, C., Binder, E.F., Azen, S.P., Sattler, F.R., N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone. J. Clin. Endocrinol. Metab. 94 (2009), 4224–4233.
8. Binkley, N., Krueger, D., Buehring, B., What's in a name revisited: should osteoporosis and sarcopenia be considered components of dysmobility syndrome?. Osteoporos. Int. 24 (2013), 2955–2959.
9. Biolo, G., Cederholm, T., Muscaritoli, M., Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin. Nutr. 33 (2014), 737–748.
10. Bloch, S.A., Lee, J.Y., Wort, S.J., Polkey, M.I., Kemp, P.R., Griffiths, M.J., Sustained elevation of circulating growth and differentiation factor-15 and a dynamic imbalance in mediators of muscle homeostasis are associated with the development of acute muscle wasting following cardiac surgery. Crit. Care Med. 41 (2013), 982–989.
11. Bloch, S.A., Lee, J.Y., Syburra, T., Rosendahl, U., Griffiths, M.J., Kemp, P.R., Polkey, M.I., Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs. Thorax 70 (2015), 219–228.
12. Bolliger, M.F., Zurlinden, A., Lüscher, D., Bütikofer, L., Shakhova, O., Francolini, M., Kozlov, S.V., Cinelli, P., Stephan, A., Kistler, A.D., Rülicke, T., Pelczar, P., Ledermann, B., Fumagalli, G., Gloor, S.M., Kunz, B., Sonderegger, P., Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J. Cell Sci. 123 (2010), 3944–3955.
13. Boström, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., Rasbach, K.A., Boström, E.A., Choi, J.H., Long, J.Z., Kajimura, S., Zingaretti, M.C., Vind, B.F., Tu, H., Cinti, S., Højlund, K., Gygi, S.P., Spiegelman, B.M., A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481 (2012), 463–468.
14. Breitbart, A., Scharf, G.M., Duncker, D., Widera, C., Gottlieb, J., Vogel, A., Schmidt, S., Brandes, G., Heuft, H.G., Lichtinghagen, R., Kempf, T., Wollert, K.C., Bauersachs, J., Heineke, J., Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients. PLoS One, 15(8), 2013, e80454.
15. Brunelli, A., Dimauro, I., Sgrò, P., Emerenziani, G.P., Magi, F., Baldari, C., Guidetti, L., Di Luigi, L., Parisi, P., Caporossi, D., Acute exercise modulates BDNF and pro-BDNF protein content in immune cells. Med. Sci. Sports Exerc. 44 (2012), 1871–1880.
16. Bütikofer, L., Zurlinden, A., Bolliger, M.F., Kunz, B., Sonderegger, P., Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia. FASEB J. 5 (2011), 4378–4393.
17. Cacciatore, F., Della-Morte, D., Basile, C., Curcio, F., Liguori, I., Roselli, M., Gargiulo, G., Galizia, G., Bonaduce, D., Abete, P., Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopenia. Biomark. Med. 9:7 (2015), 669–678.
18. Calvani, R., Marini, F., Cesari, M., Tosato, M., Anker, S.D., von Haehling, S., Miller, R.R., Bernabei, R., Landi, F., Marzetti, E., SPRINTT consortium, Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J. Cachex. Sarcopenia Muscle 6 (2015), 278–286.
19. Cesari, M., Penninx, B.W., Pahor, M., Lauretani, F., Corsi, A.M., Guralnik, J.M., Ferrucci, L., Inflammatory markers and physical performance in older persons: the InChianti study. J. Gerontol. A Biol. Sci. Med. Sci. 59 (2004), 242–248.
20. Cesari, M., Kritchevsky, S.B., Nicklas, B.J., Penninx, B.W., Holvoet, P., Koh-Banerjee, P., Cummings, S.R., Harris, T.B., Newman, A.B., Pahor, M., Lipoprotein peroxidation and mobility limitation: results from the health, aging, and body composition study. Arch. Intern. Med. 165:18 (2005), 2148–2154.
21. Chase, P.B., Szczypinski, M.P., Soto, E.P., Nuclear tropomyosin and troponin in striated muscle: new roles in a new locale?. J. Muscle Res. Cell Motil. 34 (2013), 275–284.
22. Chen, J.L., Walton, K.L., Winbanks, C.E., Murphy, K.T., Thomson, R.E., Makanji, Y., Qian, H., Lynch, G.S., Harrison, C.A., Gregorevic, P., Elevated expression of activins promotes muscle wasting and cachexia. FASEB J. 28 (2014), 1711–1723.
23. Chumlea, W.C., Cesari, M., Evans, W.J., Ferrucci, L., Fielding, R.A., Pahor, M., et al. Sarcopenia: designing phase IIB trials. J. Nutr. Health Aging 15 (2011), 450–455.
24. Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 (2010), 412–423.
25. De Rui, M., Veronese, N., Bolzetta, F., Berton, L., Carraro, S., Bano, G., et al. Validation of bioelectrical impedance analysis for estimating limb lean mass in free-living Caucasian elderly people. Clin. Nutr. 2016:5614 (2016), 30044–30049.
26. Dominguez, L.J., Barbagallo, M., Lauretani, F., Bandinelli, S., Bos, A., Corsi, A.M., Simonsick, E.M., Ferrucci, L., Magnesium and muscle performance in older persons: the InCHIANTI study. Am. J. Clin. Nutr. 84:2 (2006), 419–426.
27. Drey, M., Sieber, C.C., Bauer, J.M., Uter, W., Dahinden, P., Fariello, R.G., Vrijbloed, J.W., FiAT Intervention Group. C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction. Exp. Gerontol. 48 (2013), 76–80.
28. Dutt, V., Gupta, S., Dabur, R., Injeti, E., Mittal, A., Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action. Pharmacol. Res. 99 (2015), 86–100.
29. Feng, N., Huke, S., Zhu, G., Tocchetti, C.G., Shi, S., Aiba, T., Kaludercic, N., Hoover, D.B., Beck, S.E., Mankowski, J.L., Tomaselli, G.F., Bers, D.M., Kass, D.A., Paolocci, N., Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 1880–1885.
30. Ferrucci, L., Harris, T.B., Guralnik, J.M., Wacholder, S., Tracy, R.P., Corti, M.C., Penninx, B.W.J.H., Pahor, M., Wallace, R.B., Havlik, R.J., Inflammation, a novel risk factor for disability in older persons. J. Am. Geriatr. Soc. 47 (1999), 639–646.
31. Fuentes, T., Ara, I., Guadalupe-Grau, A., Larsen, S., Stallknecht, B., et al. Leptin receptor 170 kDa (OB-R170) protein expression is reduced in obese human skeletal muscle: a potential mechanism of leptin resistance. Exp. Physiol. 95 (2010), 160–171.
32. Gilson, H., Schakman, O., Kalista, S., Lause, P., Tsuchida, K., Thissen, J.P., Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am. J. Physiol. Endocrinol. Metab. 297:1 (2009), E157–E164.
33. Giovannini, S., Marzetti, E., Borst, S.E., Leeuwenburgh, C., Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mech. Ageing Dev. 129:10 (2008), 593–601.
34. Gonzalez-Freire, M., de Cabo, R., Studenski, S.A., Ferrucci, L., The neuromuscular junction: aging at the crossroad between nerves and muscle. Front. Aging Neurosci., 6, 2014, 208.
35. Goodpaster, B.H., Kelley, D.E., Thaete, F.L., He, J., Ross, R., Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J. Appl. Physiol. 89:1 (2000), 104–110.
36. Hamrick, M.W., Herberg, S., Arounleut, P., He, H.Z., Shiver, A., et al. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem. Biophys. Res. Commun. 400 (2010), 379–383.
37. Hettwer, S., Dahinden, P., Kucsera, S., Farina, C., Ahmed, S., Fariello, R., Drey, M., Sieber, C.C., Vrijbloed, J.W., Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients. Exp. Gerontol. 48 (2010), 69–75.
38. Hofmann, T., Elbelt, U., Stengel, A., Irisin as a muscle-derived hormone stimulating thermogenesis - a critical update. Peptides 54 (2014), 89–100.
39. Houston, D.K., Cesari, M., Ferrucci, L., Cherubini, A., Maggio, D., Bartali, B., Johnson, M.A., Schwartz, G.G., Kritchevsky, S.B., Association between vitamin D status and physical performance: the InCHIANTI study. J. Gerontol. A Biol. Sci. Med. Sci. 62:4 (2007), 440–446.
40. Howard, C., Ferrucci, L., Sun, K., Fried, L.P., Walston, J., Varadhan, R., Guralnik, J.M., Semba, R.D., Oxidative protein damage is associated with poor grip strength among older women living in the community. J. Appl. Physiol. 103:1 (2007), 17–20.
41. Ilich, J.Z., Kelly, O.J., Inglis, J.E., Panton, L.B., Duque, G., Ormsbee, M.J., Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels. Ageing Res. Rev. 15 (2014), 51–60.
42. Kalinkovich, A., Livshits, G., Sarcopenia-the search for emerging biomarkers. Ageing Res. Rev 22 (2015), 58–71.
43. Klangjareonchai, T., Nimitphong, H., Saetung, S., Bhirommuang, N., Samittarucksa, R., Chanprasertyothin, S., Sudatip, R., Ongphiphadhanakul, B., Circulating sclerostin and irisin are related and interact with gender to influence adiposity in adults with prediabetes. Int. J. Endocrinol., 2014, 261545.
44. Lafyatis, R., Lechleider, R., Roberts, A.B., Sporn, M.B., Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis. Mol. Cell. Biol. 11 (1991), 3795–3803.
45. Lauretani, F., Semba, R.D., Bandinelli, S., Ray, A.L., Guralnik, J.M., Ferrucci, L., Association of low plasma selenium concentrations with poor muscle strength in older community-dwelling adults: the InCHIANTI Study. Am. J. Clin. Nutr. 86 (2007), 347–352.
46. Lauretani, F., Bautmans, I., De Vita, F., Nardelli, A., Ceda, G.P., Maggio, M., Identification and treatment of older persons with sarcopenia. Aging Male 17 (2014), 199–204.
47. Lee, S.J., Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One, 2(8), 2007, e789.
48. Lee, S.J., McPherron, A.C., Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 9306–9311.
49. Lee, S.J., Reed, L.A., Davies, M.V., Girgenrath, S., Goad, M.E., Tomkinson, K.N., Wright, J.F., Barker, C., Ehrmantraut, G., Holmstrom, J., Trowell, B., Gertz, B., Jiang, M.S., Sebald, S.M., Matzuk, M., Li, E., Liang, L.F., Quattlebaum, E., Stotish, R.L., Wolfman, N.M., Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 18117–18122.
50. Léger, B., Derave, W., De Bock, K., Hespel, P., Russell, A.P., Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res. 11 (2008), 163–175B.
51. Liu, C.K., Leng, X., Hsu, F.C., Kritchevsky, S.B., Ding, J., Earnest, C.P., Ferrucci, L., Goodpaster, B.H., Guralnik, J.M., Lenchik, L., Pahor, M., Fielding, R.A., The impact of sarcopenia on a physical activity intervention: the lifestyle interventions and independence for elders pilot study (LIFE-P). J. Nutr. Health Aging 18 (2014), 59–64.
52. Macchi, C., Molino-Lova, R., Polcaro, P., Guarducci, L., Lauretani, F., Cecchi, F., Bandinelli, S., Guralnik, J.M., Ferrucci, L., Higher circulating levels of uric acid are prospectively associated with better muscle function in older persons. Mech. Ageing Dev. 129:9 (2008), 522–527.
53. Maggio, M., Lauretani, F., Ceda, G.P., Sex hormones and sarcopenia in older persons. Curr. Opin. Clin. Nutr. Metab. Care 16:1 (2013), 3–13.
54. Malafarina, V., Uriz-Otano, F., Iniesta, R., Gil-Guerrero, L., Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas 71 (2012), 109–114.
55. Martin, S.S., Qasim, A., Reilly, M.P., Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J. Am. Coll. Cardiol. 52 (2008), 1201–1210.
56. Marzetti, E., Calvani, R., Lorenzi, M., Marini, F., D'Angelo, E., Martone, A.M., Celi, M., Tosato, M., Bernabei, R., Landi, F., Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients. Exp. Gerontol. 60 (2014), 79–82.
57. Marzetti, E., Landi, F., Marini, F., Cesari, M., Buford, T.W., Manini, T.M., Onder, G., Pahor, M., Bernabei, R., Leeuwenburgh, C., Calvani, R., Patterns of circulating inflammatory biomarkers in older persons with varying levels of physical performance: a partial least squares-discriminant analysis approach. Front. Med. (Lausanne), 1, 2014, 27.
58. Massagué, J., Seoane, J., Wotton, D., Smad transcription factors. Genes Dev. 9:23 (2005), 2783–2810.
59. McPherron, A.C., Lawler, A.M., Lee, S.J., Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387 (1997), 83–90.
60. Melton, L.J. III, Riggs, B.L., Achenbach, S.J., Amin, S., Camp, J.J., Rouleau, P.A., Robb, R.A., Oberg, A.L., Khosla, S., Does reduced skeletal loading account for age-related bone loss. J. Bone Miner. Res. 21 (2006), 1847–1855.
61. Meng, Y., Wu, H., Yang, Y., Du, H., Xia, Y., Guo, X., Liu, X., Li, C., Niu, K., Relationship of anabolic and catabolic biomarkers with muscle strength and physical performance in older adults: a population-based cross-sectional study. BMC Musculoskelet. Disord., 16, 2015, 202.
62. Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., Nourhashemi, F., Proinflammatory cytokines, aging, and age-related diseases. J. Am. Med. Dir. Assoc. 14 (2013), 877–882.
63. Molfino, A., Amabile, M.I., Rossi Fanelli, F., Muscaritoli, M., Novel therapeutic options for cachexia and sarcopenia. Expert Opin. Biol. Ther. 11 (2016), 1–6.
64. Montero-Fernàndez, N., Serra-Rexach, J.A., Role of exercise on sarcopenia in the elderly. Eur. J. Phys. Rehabil. Med. 49 (2013), 131–143.
65. Moon, M.K., Lee, Y.J., Choi, S.H., Lim, S., Yang, E.J., Lim, J.Y., Paik, N.J., Kim, K.W., Park, K.S., Jang, H.C., Cho, B.Y., Park, Y.J., Subclinical hypothyroidism has little influences on muscle mass or strength in elderly people. J. Korean Med. Sci. 25:8 (2010), 1176–1181.
66. Morley, J.E., Abbatecola, A.M., Argiles, J.M., Baracos, V., Bauer, J., Bhasin, S., et al. Sarcopenia with limited mobility: an international consensus. J. Am. Med. Dir. Assoc. 12 (2011), 403–409.
67. Nedergaard, A., Karsdal, M.A., Sun, S., Henriksen, K., Serological muscle loss biomarkers: an overview of current concepts and future possibilities. J. Cachex. Sarcopenia Muscle 4 (2013), 1–17.
68. Nedergaard, A., Sun, S., Karsdal, M.A., Henriksen, K., Kjaer, M., Lou, Y., He, Y., Zheng, Q., Suetta, C., Type VI collagen turnover related peptides-novel serological biomarkers of muscle mass and anabolic response to loading in young men. J. Cachex. Sarcopenia Muscle 4 (2013), 267–275.
69. Papathanassoglou, E.D., Miltiadous, P., Karanikola, M.N., May BDNF be implicated in the exercise-mediated regulation of inflammation? Critical review and synthesis of evidence. Biol. Res. Nurs. 17:5 (2015), 521–539.
70. Patel, S.S., Molnar, M.Z., Tayek, J.A., Ix, J.H., Noori, N., Benner, D., Heymsfield, S., Kopple, J.D., Kovesdy, C.P., Kalantar-Zadeh, K., Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J. Cachex. Sarcopenia Muscle 4 (2013), 19–29.
71. Pedersen, B.K., Muscle as a secretory organ. Compr. Physiol. 3 (2013), 1337–1362.
72. Pedersen, B.K., Febbraio, M.A., Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8 (2012), 457–465.
73. Pedersen, L., Hojman, P., Muscle-to-organ cross talk mediated by myokines. Adipocyte 1 (2012), 164–167.
74. Penninx, B.W., Kritchevsky, S.B., Newman, A.B., Nicklas, B.J., Simonsick, E.M., Rubin, S., Nevitt, M., Visser, M., Harris, T., Pahor, M., Inflammatory markers and incident mobility limitation in the elderly. J. Am. Geriatr. Soc. 52 (2004), 1105–1113.
75. Penninx, B.W.J.H., Pahor, M., Cesari, M., Corsi, A.M., Woodman, R.C., Guralnik, J.M., Ferrucci, L., Anemia is associated with decreased physical performance and muscle strength in the elderly. J. Am. Geriatr. Soc. 52 (2004), 719–724.
76. Peterson, M.J., Thompson, D.K., Pieper, C.F., Morey, M.C., Kraus, V.B., Kraus, W.E., Sullivan, P., Fillenbaum, G., Cohen, H.J., A novel analytic technique to measure associations between circulating biomarkers and physical performance across the adult life span. J. Gerontol. A Biol. Sci. Med. Sci. 71 (2016), 196–202.
77. Proctor, D.N., Balagopal, P., Nair, K.S., Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins. J. Nutr. 128:2Suppl (1998), 351S–355S.
78. Proctor, D.N., O'Brien, P.C., Atkinson, E.J., Nair, K.S., Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am. J. Physiol. 277:3Pt1 (1999), E489–E495.
79. Rahimi, N., Tremblay, E., McAdam, L., Roberts, A., Elliott, B., Autocrine secretion of TGF-beta 1 and TGF-beta 2 by pre-adipocytes and adipocytes: a potent negative regulator of adipocyte differentiation and proliferation of mammary carcinoma cells. In Vitro Cell. Dev. Biol. Anim. 34 (1998), 412–420.
80. Raschke, S., Eckel, J., Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators Inflamm., 2013, 2013, 320724.
81. Raschke, S., Elsen, M., Gassenhuber, H., Sommerfeld, M., Schwahn, U., Brockmann, B., Jung, R., Wisløff, U., Tjønna, A.E., Raastad, T., Hallén, J., Norheim, F., Drevon, C.A., Romacho, T., Eckardt, K., Eckel, J., Evidence against a beneficial effect of irisin in humans. PLoS One, 8(9), 2013, e73680.
82. Roca-Rivada, A., Castelao, C., Senin, L.L., Landrove, M.O., Baltar, J., Belén Crujeiras, A., Seoane, L.M., Casanueva, F.F., Pardo, M., FNDC5/irisin is not only a myokine but also an adipokine. PLoS One, 8(4), 2013, e60563 (11).
83. Rosenberg, I., Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am. J. Clin. Nutr. 50 (1989), 1231–1233.
84. Roubenoff, R., Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann. N. Y. Acad. Sci. 904 (2000), 553–557.
85. Rudolf, R., Khan, M.M., Labeit, S., Deschenes, M.R., Degeneration of neuromuscular junction in age and dystrophy. Front. Aging Neurosci., 6, 2014, 99.
86. Ruschke, K., Hiepen, C., Becker, J., Knaus, P., BMPs are mediators in tissue crosstalk of the regenerating musculoskeletal system. Cell Tissue Res. 347:3 (2012), 521–544.
87. Sakuma, K., Yamaguchi, A., Sarcopenia and age-related endocrine function. Int. J. Endocrinol., 2012, 127362.
88. Sakuma, K., Aoi, W., Yamaguchi, A., The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy. Front. Aging Neurosci., 6, 2014, 230.
89. Sakuma, K., Aoi, W., Yamaguchi, A., Current understanding of sarcopenia: possible candidates modulating muscle mass. Pflugers Arch. 467 (2015), 213–229.
90. Sallam, N., Laher, I., Exercise modulates oxidative stress and inflammation in aging and cardiovascular diseases. Oxid. Med. Cell. Longev., 2016, 2016, 7239639.
91. Santilli, V., Bernetti, A., Mangone, M., Paoloni, M., Clinical definition of sarcopenia. Clin. Cases Miner. Bone Metab. 11 (2014), 177–180.
92. Sapir-Koren, R., Livshits, G., Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?. Osteoporos. Int. 25 (2014), 2685–2700.
93. Sartori, R., Gregorevic, P., Sandri, M., TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease. Trends Endocrinol. Metab. 25:9 (2014), 464–471.
94. Schalk, B.W., Deeg, D.J., Penninx, B.W., Bouter, L.M., Visser, M., Serum albumin and muscle strength: a longitudinal study in older men and women. J. Am. Geriatr. Soc. 53:8 (2005), 1331–1338.
95. Sell, H., Dietze-Schroeder, D., Eckel, J., The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol. Metab. 17 (2006), 416–422.
96. Sell, H., Habich, C., Eckel, J., Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol. 8 (2012), 709–716.
97. Semba, R.D., Lauretani, F., Ferrucci, L., Carotenoids as protection against sarcopenia in older adults. Arch. Biochem. Biophys. 458:2 (2007), 141–145.
98. Sheffield-Moore, M., Dillon, E.L., Randolph, K.M., Casperson, S.L., White, G.R., Jennings, K., Rathmacher, J., Schuette, S., Janghorbani, M., Urban, R.J., Hoang, V., Willis, M., Durham, W.J., Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss. J. Cachex. Sarcopenia Muscle 5 (2013), 19–25.
99. Sjöblom, S., Suuronen, J., Rikkonen, T., Honkanen, R., Kröger, H., Sirola, J., Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas 75 (2013), 175–180.
100. Stimpson, S.A., Leonard, M.S., Clifton, L.G., Poole, J.C., Turner, S.M., Shearer, T.W., Remlinger, K.S., Clark, R.V., Hellerstein, M.K., Evans, W.J., Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3-creatine dilution method. J. Cachex. Sarcopenia Muscle 4:3 (2013), 217–223.
101. Stout, J.R., Fragala, M.S., Hoffman, J.R. 4th, Robinson, E.H., Mccormack, W.P., Townsend, J.R., Jatjner, A.R., Emerson, N.S., Oliveira, L.P., Fukuda, D.H., C-terminal agrin fragment is inversely related to neuromuscular fatigue in older men. Muscle Nerve 51 (2015), 132–133.
102. Trendelenburg, A.U., Meyer, A., Jacobi, C., Feige, J.N., Glass, D.J., TAK-1/p38/nNF_B signaling inhibits myoblast differentiation by increasing levels of Activin A. Skelet. Muscle, 2, 2012, 3.
103. Vamvini, M.T., Aronis, K.N., Panagiotou, G., Huh, J.Y., Chamberland, J.P., Brinkoetter, M.T., Petrou, M., Christophi, C.A., Kales, S.N., Christiani, D.C., Mantzoros, C.S., Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Eur. J. Endocrinol. 169 (2013), 829–834.
104. Visser, M., Pahor, M., Taaffe, D., Goodpaster, B.H., Simonsick, E., Newman, A.B., Nevitt, M.C., Harris, T.B., Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci. 57 (2002), M326–M332.
105. Visser, M., Deeg, D.J., Lips, P., Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J. Clin. Endocrinol. Metab. 88:12 (2003), 5766–5772.
106. Visser, M., Kritchevsky, S.B., Newman, A.B., Goodpaster, B.H., Tylavsky, F.A., Nevitt, M.C., et al. Lower serum albumin concentration and change in muscle mass: the Health, Aging and Body Composition Study. Am. J. Clin. Nutr. 82 (2005), 531–537.
107. Watanabe, S., Sato, K., Hasegawa, N., Kurihara, T., Matsutani, K., Sanada, K., Hamaoka, T., Fujita, S., Iemitsu, M., Serum C1q as a novel biomarker of sarcopenia in older adults. FASEB J. 29:3 (2015), 1003–1010.
108. Yarasheski, K.E., Bhasin, S., Sinha-Hikim, I., Pak-Loduca, J., Gonzalez-Cadavid, N.F., Serum myostatin-immunoreactive protein is increased in 60–92 year old women and men with muscle wasting. J. Nutr. Health Aging 6 (2002), 343–348.
109. Young, V.R., Munro, H.N., Ntaumethylhistidine (3-methylhistidine) and muscle protein turnover: an overview. Fed. Proc. 37 (1978), 2291–2300.
110. Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., Di Francesco, V., Sarcopenic obesity: a new category of obesity in the elderly. Nutr. Metab. Cardiovasc. Dis. 18 (2008), 388–395.
111. Zhu, J., Li, Y., Lu, A., Gharaibeh, B., Ma, J., Kobayashi, T., Quintero, A.J., Huard, J., Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am. J. Pathol. 179 (2011), 915–930.